Abstract
In recent years, engineering of pH-sensitivity into antibodies as well as antibody-derived fragments has become more and more attractive for biomedical and biotechnological applications. Herein, we report the isolation of the first pH-sensitive IgNAR variable domain (vNAR), which was isolated from a yeast-displayed, semi-synthetic master library. This strategy enables the direct identification of pH-dependent binders from a histidine-enriched CDR3 library. Displayed vNAR variants contained two histidine substitutions on average at random positions in their 12-residue CDR3 loop. Upon screening of seven rounds against the proof-of-concept target EpCAM (selection for binding at pH 7.4 and decreased binding at pH 6.0), a single clone was obtained that showed specific and pH-dependent binding as characterized by yeast surface display and biolayer interferometry. Potential applications for such pH-dependent vNAR domains include their employment in tailored affinity chromatography, enabling mild elution protocols. Moreover, utilizing a master library for the isolation of pH-sensitive vNAR variants may be a generic strategy to obtain binding entities with prescribed characteristics for applications in biotechnology, diagnostics, and th...Continue Reading
References
Mar 9, 1995·Nature·A S GreenbergM F Flajnik
Jun 1, 1997·Nature Biotechnology·E T Boder, K D Wittrup
Feb 9, 2000·Biotechnology Progress·J J VanAntwerp, K D Wittrup
Apr 18, 2002·FEBS Letters·Stewart D NuttallRobert A Irving
Aug 6, 2002·Nature Biotechnology·Casim A SarkarDouglas A Lauffenburger
Aug 16, 2003·European Journal of Biochemistry·Stewart D NuttallPeter J Hudson
Mar 5, 2004·Proteins·Stewart D NuttallPeter J Hudson
Aug 21, 2004·Science·Robyn L StanfieldIan A Wilson
Apr 5, 2007·Nature Protocols·Ginger ChaoK Dane Wittrup
Feb 5, 2010·Protein Engineering, Design & Selection : PEDS·Lorenzo BenatuilChung-Ming Hsieh
Oct 5, 2010·The Journal of Biological Chemistry·Mandar V KulkarniMichael E Hodsdon
Oct 19, 2010·Nature Biotechnology·Tomoyuki IgawaKunihiro Hattori
Jan 26, 2011·Acta Oncologica·Robert KönigsbergChristian Dittrich
Jul 19, 2011·Protein Science : a Publication of the Protein Society·Megan L MurtaughJames R Horn
Feb 2, 2012·The Journal of Biological Chemistry·Javier Chaparro-RiggersArvind Rajpal
Nov 13, 2012·PloS One·Nimish GeraBalaji M Rao
Dec 12, 2012·MAbs·Tanya Camacho-VillegasAlexei Licea
Jan 2, 2014·Proceedings of the National Academy of Sciences of the United States of America·Eva-Maria StrauchDavid Baker
May 28, 2014·Journal of Biotechnology·Stefan ZielonkaHarald Kolmar
Jun 26, 2014·Biotechnology Journal·Michael W TraxlmayrChristian Obinger
Jul 25, 2014·Journal of Biological Engineering·Masayuki TsukamotoShinya Honda
Aug 16, 2014·Biochimica Et Biophysica Acta·T IgawaK Hattori
Dec 20, 2014·MAbs·Stefan ZielonkaHarald Kolmar
Dec 20, 2014·MAbs·Christian SchröterBjörn Hock
Jan 22, 2015·MAbs·Pauline BonvinNicolas Fischer
Citations
Nov 24, 2016·Biotechnology Journal·Julius GrzeschikHarald Kolmar
Mar 9, 2017·Protein Science : a Publication of the Protein Society·Thomas Böldicke
Nov 2, 2018·Biochemical Society Transactions·Obinna C UbahCaroline J Barelle
Feb 28, 2018·Microbial Cell Factories·Doreen Könning, Harald Kolmar
Jan 11, 2018·Microbial Cell Factories·Simon RosowskiSimon Krah
Nov 30, 2019·MAbs·Traian SuleaJohn C Zwaagstra
Mar 3, 2020·Protein Engineering, Design & Selection : PEDS·Magdalena J BuschhausCaroline J Barelle
Apr 29, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Henk van FaassenGreg Hussack
Aug 31, 2017·Scientific Reports·Doreen KönningHarald Kolmar
Jul 14, 2020·Frontiers in Bioengineering and Biotechnology·Steffen C HinzHarald Kolmar
Dec 17, 2020·Frontiers in Immunology·Arturo Macarrón PalaciosHarald Kolmar
Mar 7, 2021·Biomolecules·Shih-Ting HongYeng-Tseng Wang
Mar 25, 2021·Biological Chemistry·Bernhard ValldorfStefan Zielonka
Oct 10, 2019·ACS Chemical Biology·Hideki WatanabeShinya Honda